The German Cancer Award 2019 has been given to Ugur Sahin, the co-founder and chief executive of BioNTech AG for his work on individualised cancer immunotherapies and in particular, the development and clinical testing of messenger RNA (mRNA)-based cancer vaccines tailored to an individual patient’s cancer mutation profile.
